Provided by Tiger Trade Technology Pte. Ltd.

IceCure Medical Ltd.

2.31
+0.04001.76%
Volume:55.35K
Turnover:126.08K
Market Cap:7.91M
PE:-0.35
High:2.33
Open:2.33
Low:2.20
Close:2.27
52wk High:42.00
52wk Low:2.12
Shares:3.43M
Float Shares:2.20M
Volume Ratio:0.35
T/O Rate:2.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.6592
EPS(LYR):-7.1047
ROE:-228.31%
ROA:-73.88%
PB:0.67
PE(LYR):-0.33

Loading ...

IceCure Medical files to sell 16M ordinary share for holders

TIPRANKS
·
Apr 02

IceCure prices $4.0 million registered direct offering at $0.50 per share; adds Series B and C warrants at $0.55 exercise price

Reuters
·
Mar 26

Icecure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement

THOMSON REUTERS
·
Mar 26

IceCure Medical files Form 3 initial beneficial ownership statement; director Ron Mayron reports 296,631 ordinary shares

Reuters
·
Mar 26

IceCure Medical; CEO and director Eyal Shamir files initial beneficial ownership statement```

Reuters
·
Mar 26

IceCure Medical Posts Strong 5-Year Kidney Cancer Cryoablation Data From ICESECRET Trial

TIPRANKS
·
Mar 25

IceCure Medical reports results from clinical trial of ProSense for SRMs

TIPRANKS
·
Mar 25

IceCure reports ICESECRET ProSense kidney cancer trial; recurrence-free rate rises to 89.4% for tumors ≤3 cm

Reuters
·
Mar 25

Icecure Medical Ltd - 89.4% Recurrence-Free Rate for Tumors ≤3 Cm, 83.9% for General Population at 4 Years

THOMSON REUTERS
·
Mar 25

Icecure Reports Positive 5-Year Top-Line Results From Icesecret Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates

THOMSON REUTERS
·
Mar 25

IceCure Medical Names New CFO and Plans Key Leadership Changes Amid ProSense® Growth

TIPRANKS
·
Mar 24

IceCure names Meir Peleg CFO effective May 17, 2026

Reuters
·
Mar 24

BRIEF-Icecure Appoints Meir Peleg As Chief Financial Officer

Reuters
·
Mar 24

Icecure Appoints Meir Peleg as Chief Financial Officer

THOMSON REUTERS
·
Mar 24

Press Release: IceCure Appoints Meir Peleg as Chief Financial Officer

Dow Jones
·
Mar 24

Icecure Medical Rides FDA, ASBRS Wins to Growth

TIPRANKS
·
Mar 18

IceCure Medical Director Li Haixiang Resigns Effective March 17, 2026

Reuters
·
Mar 18

IceCure Medical reports FY25 EPS 24c vs 30c last year

TIPRANKS
·
Mar 17

Israel's IceCure Medical 2025 gross margin falls to 36% on higher costs

Reuters
·
Mar 17

Icecure Medical Q4 EPS $(0.06) Misses $(0.04) Estimate, Sales $1.279M Miss $1.900M Estimate

Benzinga Earnings
·
Mar 17